» Articles » PMID: 22740910

MicroRNA Expression Profiles in Human Colorectal Cancers with Brain Metastases

Overview
Journal Oncol Lett
Specialty Oncology
Date 2012 Jun 29
PMID 22740910
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to identify microRNA (miRNA) expression profiles associated with brain metastases of colorectal cancers. We conducted miRNA expression profiling of 3 primary colorectal cancers and 3 brain-metastatic carcinomas using Agilent Human miRNA Microarrays. Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) was employed to validate the results obtained from the miRNA microarray analysis. Overexpression of miR-145, miR-1, miR-146a, miR-576-5p, miR-126*, HS287, miR-28-5p, miR-143, miR-199b-5p, miR-199a-5p, miR-10b, miR-22, miR-133b, miR-145*, miR-199a, miR-133a, miR-125b and downregulation of miR-31 and HS170 were observed in brain-metastatic carcinomas. Quantitative RT-PCR experiments with miR-125b confirmed the expression patterns we found in our microarray experiments. miRNAs are differentially expressed between colorectal cancers and matched brain-metastatic carcinomas. The miRNA variation trend is quite different in the process of metastasis compared to that of carcinogenesis. These miRNAs may therefore serve as potential diagnostic markers and therapeutic targets for colorectal cancers with brain metastases.

Citing Articles

MiRNAs as new potential biomarkers and therapeutic targets in brain metastasis.

Beylerli O, Shi H, Begliarzade S, Shumadalova A, Ilyasova T, Sufianov A Noncoding RNA Res. 2024; 9(3):678-686.

PMID: 38577014 PMC: 10987301. DOI: 10.1016/j.ncrna.2024.02.014.


Cell-Free miRNAs as Non-Invasive Biomarkers in Brain Tumors.

Beylerli O, Encarnacion Ramirez M, Shumadalova A, Ilyasova T, Zemlyanskiy M, Beilerli A Diagnostics (Basel). 2023; 13(18).

PMID: 37761255 PMC: 10529040. DOI: 10.3390/diagnostics13182888.


Advances in Brain Metastases Diagnosis: Non-coding RNAs As Potential Biomarkers.

Eraky A Cureus. 2023; 15(3):e36337.

PMID: 37077610 PMC: 10109215. DOI: 10.7759/cureus.36337.


miR-576-5p Promotes the Proliferation of Papillary Thyroid Carcinoma through the MAPK4-AKT Pathway.

Hai R, Zhou Y, Li F, Guo Q, Long Y, Wang F Int J Anal Chem. 2023; 2022:1428411.

PMID: 36618768 PMC: 9815926. DOI: 10.1155/2022/1428411.


The Significance of MicroRNAs in the Molecular Pathology of Brain Metastases.

Siegl F, Vecera M, Roskova I, Smrcka M, Jancalek R, Kazda T Cancers (Basel). 2022; 14(14).

PMID: 35884446 PMC: 9322877. DOI: 10.3390/cancers14143386.


References
1.
Gee H, Camps C, Buffa F, Colella S, Sheldon H, Gleadle J . MicroRNA-10b and breast cancer metastasis. Nature. 2008; 455(7216):E8-9. DOI: 10.1038/nature07362. View

2.
Aprile G, Zanon E, Tuniz F, Iaiza E, De Pauli F, Pella N . Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases. J Cancer Res Clin Oncol. 2008; 135(3):451-7. DOI: 10.1007/s00432-008-0468-1. View

3.
Pantaleo M, Astolfi A, Nannini M, Paterini P, Piazzi G, Ercolani G . Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer. 2008; 99(10):1729-34. PMC: 2584956. DOI: 10.1038/sj.bjc.6604681. View

4.
Sarver A, French A, Borralho P, Thayanithy V, Oberg A, Silverstein K . Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer. 2009; 9:401. PMC: 2787532. DOI: 10.1186/1471-2407-9-401. View

5.
Ng E, Tsang W, Ng S, Jin H, Yu J, Li J . MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer. 2009; 101(4):699-706. PMC: 2736825. DOI: 10.1038/sj.bjc.6605195. View